Literature DB >> 16026760

SMRT has tissue-specific isoform profiles that include a form containing one CoRNR box.

Stephen Short1, Marianne Malartre, Colin Sharpe.   

Abstract

SMRT acts as a corepressor for a range of transcription factors. The amino-terminal part of the protein includes domains that mainly mediate transcriptional repression whilst the carboxy-terminal part includes domains that interact with nuclear receptors using up to three motifs called CoRNR boxes. The region of the SMRT primary transcript encoding the interaction domains is subject to alternative splicing that varies the inclusion of the third CoRNR box. The profile in mice includes an abundant, novel SMRT isoform that possesses just one CoRNR box. Mouse tissues therefore express SMRT isoforms containing one, two or three CoRNR boxes. In frogs, the SMRT isoform profile is tissue-specific. The mouse also shows distinct profiles generated by differential expression levels of the SMRT transcript isoforms. The formation of multiple SMRT isoforms and their tissue-specific regulation indicates a mechanism, whereby cells can define the repertoire of transcription factors regulated by SMRT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026760     DOI: 10.1016/j.bbrc.2005.06.175

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  SMRTε, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors α and β.

Authors:  Brenda J Mengeling; Michael L Goodson; William Bourguet; Martin L Privalsky
Journal:  Mol Cell Endocrinol       Date:  2012-01-12       Impact factor: 4.102

2.  Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation.

Authors:  Michael L Goodson; Brenda J Mengeling; Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

3.  Aberrant corepressor interactions implicated in PML-RAR(alpha) and PLZF-RAR(alpha) leukemogenesis reflect an altered recruitment and release of specific NCoR and SMRT splice variants.

Authors:  Brenda J Mengeling; Theresa Q Phan; Michael L Goodson; Martin L Privalsky
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

4.  Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling.

Authors:  Chelsea A Snyder; Michael L Goodson; Amy C Schroeder; Martin L Privalsky
Journal:  Mol Cell Endocrinol       Date:  2015-07-10       Impact factor: 4.102

5.  The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo.

Authors:  Inna Astapova; Larissa J Lee; Crystal Morales; Stefanie Tauber; Martin Bilban; Anthony N Hollenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-03       Impact factor: 11.205

6.  Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing.

Authors:  Brian A Jonas; Natalia Varlakhanova; Fumihiko Hayakawa; Michael Goodson; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2007-05-22

Review 7.  Nuclear hormone receptor co-repressors: structure and function.

Authors:  Peter J Watson; Louise Fairall; John W R Schwabe
Journal:  Mol Cell Endocrinol       Date:  2011-09-08       Impact factor: 4.102

8.  MicroRNA-184 downregulates nuclear receptor corepressor 2 in mouse spermatogenesis.

Authors:  Jingwen Wu; Jianqiang Bao; Li Wang; Yanqin Hu; Chen Xu
Journal:  BMC Dev Biol       Date:  2011-10-24       Impact factor: 1.978

9.  Corepressors: custom tailoring and alterations while you wait.

Authors:  Michael Goodson; Brian A Jonas; Martin A Privalsky
Journal:  Nucl Recept Signal       Date:  2005-10-21

10.  Corepressor/coactivator paradox: potential constitutive coactivation by corepressor splice variants.

Authors:  Xianwang Meng; Vishnuka D Arulsundaram; Ahmed F Yousef; Paul Webb; John D Baxter; Joe S Mymryk; Paul G Walfish
Journal:  Nucl Recept Signal       Date:  2006-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.